| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/28/2011 | CN101491519B Bilobalide injector and preparation method thereof |
| 09/28/2011 | CN101437545B Hydrogel sheet and production method thereof |
| 09/28/2011 | CN101336968B Preparation method of lipid microspheres combined by salvia lipid extract and poppy seed oil |
| 09/28/2011 | CN101229187B Simethicone emulsion and preparing method thereof |
| 09/28/2011 | CN101212984B Process for attaching effector molecules to proteins |
| 09/28/2011 | CN101098714B Compositions comprising azelastine and methods of use thereof |
| 09/28/2011 | CN101066410B Chinese medicine preparation for treating women's chronic pelvic inflammation and its preparation process |
| 09/28/2011 | CN101039695B Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| 09/27/2011 | USRE42755 Honey based wound dressing |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026327 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 09/27/2011 | US8026286 Pharmaceutical compositions providing enhanced drug concentrations |
| 09/27/2011 | US8026285 Control release of biologically active compounds from multi-armed oligomers |
| 09/27/2011 | US8026276 Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant |
| 09/27/2011 | US8026238 Topical antifungal composition |
| 09/27/2011 | US8026214 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides |
| 09/27/2011 | US8026211 Methods and formulations for increasing intestinal function |
| 09/27/2011 | US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2011 | US8025903 Composite bone graft substitute cement and articles produced therefrom |
| 09/27/2011 | US8025901 Bifunctional-modified hydrogels |
| 09/27/2011 | US8025898 Enhanced drug delivery in transdermal systems |
| 09/27/2011 | US8025897 Ibuprofen composition |
| 09/27/2011 | CA2537421C Peptides and compounds that bind to thrombopoietin receptor |
| 09/27/2011 | CA2505742C Pharmaceutical compositions comprising a basic drug, a water soluble acid and a surfactant |
| 09/27/2011 | CA2503982C Sincalide formulations |
| 09/27/2011 | CA2495864C Aripiprazole complex formulation and method |
| 09/27/2011 | CA2495280C Topical pharmaceutical carrier |
| 09/27/2011 | CA2490309C Anthelmintic oral homogeneous veterinary pastes |
| 09/27/2011 | CA2463865C Dimeric compounds and their use as anti-viral agents |
| 09/27/2011 | CA2463835C Dimeric compounds and their use as anti-viral agents |
| 09/27/2011 | CA2445347C An orally administered agent and an orally administered agent/supporting substrate complex |
| 09/27/2011 | CA2405811C Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases |
| 09/27/2011 | CA2385465C .alpha.-isomaltosylglucosaccharide-forming enzyme, process and uses of the same |
| 09/22/2011 | WO2011116371A2 Polyplex gene delivery vectors |
| 09/22/2011 | WO2011116312A1 Fatty acid macrolide derivatives and their uses |
| 09/22/2011 | WO2011116286A2 Stable bortezomib formulations |
| 09/22/2011 | WO2011116115A1 Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing |
| 09/22/2011 | WO2011115555A1 System for improved delivery of gene modulating compounds |
| 09/22/2011 | WO2011115489A2 Spray-pumpable composition suitable for topical skin application |
| 09/22/2011 | WO2011115342A1 Oral contrast medium for contrast of small intestine |
| 09/22/2011 | WO2011115264A1 Composition for transnasal administration and method for producing same |
| 09/22/2011 | WO2011115067A1 Method for improving dissolvability of anticoagulant |
| 09/22/2011 | WO2011115007A1 Organic/inorganic composite filler and manufacturing method therefor |
| 09/22/2011 | WO2011114515A1 Manufacturing method for soft capsule using non-animal origin outer-skin, and soft capsule |
| 09/22/2011 | WO2011114225A1 Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 09/22/2011 | WO2011114002A1 Novel device |
| 09/22/2011 | WO2011113989A1 Cationic nanogels for biotechnological uses |
| 09/22/2011 | WO2011113855A2 Pharmaceutical composition for treatment of increased intraocular pressure |
| 09/22/2011 | WO2011113320A1 Pharmaceutical compositions comprising dronedarone |
| 09/22/2011 | WO2011063178A3 Intravenous infusion of curcumin and a calcium channel blocker |
| 09/22/2011 | WO2011057225A3 Self-assembled particles from zwitterionic polymers and related methods |
| 09/22/2011 | WO2011057219A3 Crosslinked zwitterionic hydrogels |
| 09/22/2011 | WO2011057180A3 Compositions of apatite and methods of use |
| 09/22/2011 | WO2011053618A3 Hydroxyl-terminated dendrimers |
| 09/22/2011 | WO2011053003A3 Gastric-retentive sustained release formulation containing pregabalin, polyethyleneoxide and pva-peg graft copolymer |
| 09/22/2011 | WO2011050206A3 Compositions and methods for the treatment of sinonasal disorders |
| 09/22/2011 | WO2011050178A3 Targeted prdm gene or protein modulation therapeutic agents |
| 09/22/2011 | US20110230569 Lipid formulations comprising a thiolated antioxidant |
| 09/22/2011 | US20110230568 Heating of polymers and other materials using radiation for drug delivery and other applications |
| 09/22/2011 | US20110230567 Vinyl alcohol co-polymer cryogels, vinyl alcohol co-polymers, and methods and products thereof |
| 09/22/2011 | US20110230565 Novel compound containing vanillin and ethylvanillin, and preparation and applications thereof |
| 09/22/2011 | US20110230561 Medical adhesive compositions |
| 09/22/2011 | US20110230455 Aqueous-based pharmaceutical composition |
| 09/22/2011 | US20110230408 Human growth hormone aqueous formulation |
| 09/22/2011 | US20110230406 Affinity peptides toward bmp-2 |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/22/2011 | US20110229569 Compositions exhibiting delayed transit through the gastrointestinal tract |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229558 Agent for treating myelofibrosis |
| 09/22/2011 | US20110229555 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 09/22/2011 | US20110229529 Lipid vesicle compositions and methods of use |
| 09/22/2011 | US20110229527 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
| 09/22/2011 | US20110229524 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of Gastric Cancer and other cancers |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | DE102010011919A1 Liquid composition, useful for treating e.g. type II diabetes mellitus, and/or obesity, comprises a glucagon-like peptide-1 agonist and/or its salt e.g. exendin-4, optionally an adjuvant and methionine |
| 09/22/2011 | CA2793686A1 Pharmaceutical compositions comprising a pancreatic enzyme preparation with viral infectivity reduced below a significant level and methods of preparing and using the same |
| 09/22/2011 | CA2793663A1 Polyplex gene delivery vectors |
| 09/22/2011 | CA2793604A1 Lipid vesicle compositions and methods of use |
| 09/22/2011 | CA2793525A1 Method for improving dissolution of anticoagulant agent |
| 09/22/2011 | CA2792764A1 Spray-pumpable composition suitable for topical skin application |
| 09/22/2011 | CA2792749A1 Composition for nasal administration and method for preparing it |
| 09/22/2011 | CA2792733A1 Fat-binding compositions comprising .alpha.- or .beta.-cyclodextrin |
| 09/22/2011 | CA2788060A1 Pharmaceutical composition for treatment of increased intraocular pressure |
| 09/21/2011 | EP2366720A1 Low-substituted hydroxypropylcellulose and solid preparation comprising the same |
| 09/21/2011 | EP2366408A1 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 09/21/2011 | EP2366404A2 Polysaccharide-protein conjugate vaccines |
| 09/21/2011 | EP2366403A2 Polysaccharide-protein conjugate vaccines |
| 09/21/2011 | EP2366401A1 Aqueous composition containing follicle-stimulating hormone |
| 09/21/2011 | EP2366399A1 Non-cytotoxic protein conjugates |
| 09/21/2011 | EP2366396A1 Myocardial perfusion imaging using adenosine receptor agonists |
| 09/21/2011 | EP2366395A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis |
| 09/21/2011 | EP2366386A1 Nanoparticulate systems prepared from anionic polymers |
| 09/21/2011 | EP2366385A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 09/21/2011 | EP2366384A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366383A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366382A2 Pharmaceutical formulation |
| 09/21/2011 | EP2366378A1 Sustained-release donepezil formulations |
| 09/21/2011 | EP2365820A2 Endothelium mimicking nanomatrix |